- Home
- NXPI vs GSK Comparison
NXPI vs GSK Comparison
Compare NXPI & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPI
- GSK
- Stock Information
- Founded
- NXPI 2006
- GSK 1715
- Country
- NXPI Netherlands
- GSK United Kingdom
- Employees
- NXPI N/A
- GSK N/A
- Industry
- NXPI Semiconductors
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- NXPI Technology
- GSK Health Care
- Exchange
- NXPI Nasdaq
- GSK Nasdaq
- Market Cap
- NXPI 59.7B
- GSK 89.9B
- IPO Year
- NXPI 2010
- GSK N/A
- Fundamental
- Price
- NXPI $231.77
- GSK $42.46
- Analyst Decision
- NXPI Buy
- GSK Buy
- Analyst Count
- NXPI 18
- GSK 5
- Target Price
- NXPI $293.22
- GSK $48.00
- AVG Volume (30 Days)
- NXPI 2.4M
- GSK 3.4M
- Earning Date
- NXPI 11-04-2024
- GSK 10-30-2024
- Dividend Yield
- NXPI 1.75%
- GSK 3.63%
- EPS Growth
- NXPI 1.03
- GSK N/A
- EPS
- NXPI 10.68
- GSK 1.24
- Revenue
- NXPI $13,109,000,000.00
- GSK $39,741,175,591.00
- Revenue This Year
- NXPI N/A
- GSK $7.53
- Revenue Next Year
- NXPI $8.62
- GSK $5.77
- P/E Ratio
- NXPI $21.53
- GSK $16.96
- Revenue Growth
- NXPI N/A
- GSK 7.20
- 52 Week Low
- NXPI $167.21
- GSK $33.67
- 52 Week High
- NXPI $296.08
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- NXPI 43.75
- GSK 48.75
- Support Level
- NXPI $225.33
- GSK $42.95
- Resistance Level
- NXPI $231.88
- GSK $43.62
- Average True Range (ATR)
- NXPI 7.67
- GSK 0.52
- MACD
- NXPI -0.51
- GSK -0.21
- Stochastic Oscillator
- NXPI 31.10
- GSK 0.83
About NXPI NXP Semiconductors N.V.
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.